Ofev (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases

25 May 2020 - Ofev slowed lung function decline in PF-ILD patients by 57% compared to placebo. ...

Read more →

Mithra and Searchlight Pharma announce filing of new drug submission for Estelle in Canada

20 May 2020 - Searchlight Pharma's new drug submission for a novel combined oral contraceptive accepted for review by Health Canada. ...

Read more →

Health Canada grants market authorisation to Rozlytrek (entrectinib) for ROS1-positive, locally advanced or metastatic non-small cell lung cancer patients, not previously treated with crizotinib

20 May 2020 - Data show responses in 73% of patients who were treated with Rozlytrek. ...

Read more →

Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market

19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...

Read more →

COVID-19 exposes drug supply gaps as 'made in Canada' solution proposed

10 May 2020 - For more than a decade, Canada has had a supply shortage of essential medication, an issue ...

Read more →

AbbVie receives Health Canada approval for the combination of Venclexta (venetoclax) with obinutuzumab for patients with previously untreated chronic lymphocytic leukaemia

5 May 2020 - Venclexta (venetoclax) plus obinutuzumab is the first chemotherapy-free, fixed-duration combination regimen approved by Health Canada for patients ...

Read more →

Teva Canada announces the launch of Ajovy for the preventive treatment of migraine in adults who have at least four migraine days per month

29 April 2020 - Ajovy is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive ...

Read more →

Health Canada approves Rozlytrek (entrectinib) for NTRK gene fusion-positive solid tumours in locally advanced or metastatic patients

28 April 2020 - Data show more than half of trial patients across all 10 tumour types studied had responses to ...

Read more →

Health Canada issues warning against use of hydroxychloroquine for COVID-19

26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...

Read more →

Canada’s Apotex donates two million dosages of hydroxychloroquine to the Public Health Agency of Canada

21 April 2020 - Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile. ...

Read more →

Alk announces Health Canada approval of Itulatek SLIT tablets for the treatment of tree pollen allergy

20 April 2020 - Over 20% of Canadians with allergies are impacted by tree pollen. ...

Read more →

Crisis or not, Alberta must not do an end-run around Health Canada

20 April 2020 - On April 12, in response to a perceived delay in Health Canada’s approval of a Canadian-made ...

Read more →

Knight Therapeutics announces approval of Ibrelsa in Canada

17 April 2020 - Knight Therapeutics announced that Health Canada has approved Ibrelsa (tenapanor) for the treatment of irritable ...

Read more →

Health Canada approves an extended indication for Kisqali (ribociclib) in combination treatment

16 April 2020 - Breast cancer is the most common female cancer in Canada. ...

Read more →

Alberta may circumvent Health Canada to gain access to COVID-19 tests and drugs, premier says

13 April 2020 - Dr. Theresa Tam says Health Canada has 'significant concerns' about the quality of some tests. ...

Read more →